Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.01. | Arcutis Biotherapeutics, Inc.: ZORYVE (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids | 288 | GlobeNewswire (Europe) | New subgroup analysis from STRATUM study shows that individuals with an inadequate response, contraindication, or intolerance to steroids were 3.5 times more likely to achieve IGA Success with ZORYVE... ► Artikel lesen | |
14.01. | Arcutis Biotherapeutics, Inc.: Majority of Individuals with Atopic Dermatitis Improved with Arcutis' Roflumilast Cream 0.15% According to New Data from Phase 3 Program | 309 | GlobeNewswire (Europe) | Individual patient response data highlight 91.5% of individuals treated with roflumilast cream had a measurable improvement in Eczema Area and Severity Index (EASI) in just 4 weeks85% achieved measurable... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 3.664 |
NEL | 2.571 |
PALANTIR TECHNOLOGIES | 2.441 |
TUI | 1.997 |
BAYER | 1.891 |
NVIDIA | 1.809 |
BIONTECH | 1.575 |
DEUTSCHE BANK | 1.481 |
BYD | 1.478 |
SUPER MICRO COMPUTER | 1.451 |
MERCEDES-BENZ | 1.382 |
RHEINMETALL | 1.292 |
INFINEON | 1.280 |
PLUG POWER | 1.146 |
RWE | 1.122 |
AIXTRON SE | 1.111 |
TESLA | 1.079 |
DEUTSCHE LUFTHANSA | 1.076 |
RENK GROUP | 1.052 |
VARTA | 1.026 |
COMMERZBANK | 984 |
ALLIANZ | 964 |
SIEMENS ENERGY | 947 |
VOLKSWAGEN | 931 |
BASF | 917 |